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New Zealand mice, particularly the  (NZB  ×  NZW)Fa mice  (NZB  ×  W)  have 
been extensively used as an experimental model of human systemic lupus erythema- 
tosus  (SLE) x  (1-4).  Among  the  murine  disease's  postulated  etiologic  factors  are 
retroviruses  (5,  6),  thymic atrophy or failure (7),  anti-thymocyte antibodies  (8, 9), 
immunologic hyperreactivity (10,  11), deficiency in suppressor T  cells (12,  13)  and 
other subsets of T  cells (14), abnormalities of phagocytic cells (15), and abnormal T- 
cell cytotoxicity (16). Attempts at genetic analysis have indicated that multiple genes 
are involved in the expression of the disease in the NZB  ×  W mice (17). Clearly these 
mice demonstrate many immunologic, virologic, and other abnormalities, and it is 
extremely difficult to determine which are primary etiologic factors of the murine 
SLE syndrome and which are secondary or even incidental features. 
To  help  identify the  essential  elements  in  murine  SLE,  we  have  undertaken  a 
comparison of immunologic, virologic, and genetic features of NZB and NZB  ×  W 
mice with those of the newly described murine strains, substrains MRL/1 and MRL/n, 
and strain BXSB  (18,  19), which also develop a  SLE-like disease. If the disorders of 
these several kinds of mice represent  a  single disease, one might expect to find the 
essential etiologic and pathologic factors present in all the mice. The studies reported 
here indicate that the lupus-like syndromes of NZB  ×  W, MRL/1, and BXSB mice 
are clinically and immunopathologically quite similar, as alike as those of randomly 
selected  humans  with  SLE  (20).  All  these  mice  have  B-cell  hyperactivity,  auto 
antibodies, circulating immune complexes (IC), abnormalities of Ig and complement, 
extensive thymic cortical atrophy, and severe IC-type glomerulonephritis with retro- 
viral  gp70  glomerular  deposits.  The  major  differences among  the  strains  are  the 
amounts and specificities of autoantibodies, age of onset and rapidity of progress of 
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disease,  incidence by sex, evidence of arteritis, and extent and nature of lymphoid 
hyperplasia. 
Materials and Methods 
Mice.  NZB  (H-2  d)  and NZW (H-2  z)  mice were originally obtained from the Laboratory 
Animals Centre, Medical Research Council, Surrey, England and have been maintained by 
brother-sister matings since 1965 at Scripps Clinic and Research Foundation. Mating of NZB 
females with NZW males produced the NZB  ×  W  hybrids (H-2d/H-2Z).  The inbred strains 
BXSB (H-2b),  MRL/1, and MRL/n (H-2  k) were obtained from the research colony of Dr. E. 
D.  Murphy of the Jackson Laboratory, Bar Harbor, Maine. BXSB is a  recombinant inbred 
strain derived from a cross between a C57BL/6 female and an SB/Le male. Nearly 100% of the 
BXSB develop a spontaneous progressive  lethal SLE-like disease affecting males much earlier 
than females.  The autoimmune phenotype is transmitted as a  dominant trait to F1  hybrids 
with an accelerating factor in males contributed by the BXSB male parent (19). The MRL 
substrains were derived mainly from strain LG/J with contributions from AKR/J, C3H/Di, 
and C57BL/6J.  A spontaneous autosomal recessive mutation, lpr (lymphoproliferation), pro- 
ducing massive T-cell proliferation and an early onset SLE-like syndrome was first observed at 
the 12th generation of inbreeding (18). Two inbred substrains sharing ~  89% of their genomes 
were  developed:  MRL/I  (lpr/lpr),  with  massive lymphoproliferation, and MRL/n  (+/+), 
without. 
All mice were maintained on 6-10% lipid, 24% protein diet, and water ad lib. 
Histology.  Mice were sacrificed when moribund  and autopsied. Sections of thymuses, spleens, 
mesenteric and peripheral lymph nodes, hearts, lungs, livers, kidneys, and gonads were fixed in 
Bouin's fluid and stained with H&E and PAS. 
Immunofluorescence Studies.  Kidneys from 27 females NZB X W (5-9-mo-old), 13 male BXSB 
(3-5-mo-old), and 11  male MRS/1 (2-5-mo-old) mice were studied for IgG and C3 by direct 
immunofluorescence  (21). Murine retroviral antigens, gp70 and p30, were sought by using goat 
anti-Rauscher virus gp70  (supplied by J.  T.  August, Johns  Hopkins University, School of 
Medicine, Baltimore, Maryland) and goat anti-Rauscher p30 antisera, respectively, followed 
by fluorescein isothiocyanate (FITC) conjugated rabbit anti-goat IgG serum (22). The anti- 
gpT0 serum had virtually no anti-p30 activity when tested by radioimmune assay; however, the 
anti-p30 serum did contain a low level of reactivity against Rauscher gp70 antigen. 
Urinary Protein.  24-h urinary protein was determined by the sulfosalicylic acid precipitation 
method (23). Values in excess of 2 mg/24 h were considered abnormal. 
Serologic Studies.  Samples of serum were analyzed electrophoretically on cellulose acetate 
membranes. Levels  of serum IgG and IgM were measured by radial immunodiffusion using 
rabbit anti-mouse IgG and rabbit anti-mouse IgM. The Coomb's test was used to detect anti- 
erythrocyte antibodies (24). Anti-nuclear antbody (ANA)  titers were determined as described 
(4) using immunofluorescence and serial fourfold serum dilutions up to  1:192. Anti-ds DNA 
and  anti-ss  DNA  antibodies  were  titrated  by  a  modification  of  the  Farr  DNA-binding 
radioimmune assay  (25),  and  the  presence of antibodies to  Sin, an  acidic soluble nuclear 
protein, was determined as in (26). Presence of IgM rheumatoid factor (RF) was assessed by a 
solid phase radioimmune assay performed as follows:  100/~l of a  10 ~g/ml solution of mouse 
IgG were used to coat the cells of microtiter plates in a reaction that lasted for 5 h at 24°C. 
After washing, the wells were further coated with 0.5% solution of bovine serum albumin before 
100/~l of a  1  : 1000 dilution of test serum samples were added. The plates were then incubated 
o  125  overnight at 4  C and washed. Then 1 ng of  I labeled anti-mouse IgM (affinity purified) was 
added, and the plates were incubated another 5 h  at 4°C. After a  final series of washes,  the 
individual  wells of the plates were cut out for counting. Each sample was simultaneously  tested 
at a  1:10,000 dilution for IgM concentration in a parallel assay that differed only in that the 
wells were coated initially with  1 /ag/ml anti-mouse IgM instead of mouse IgG. A standard 
curve was determined by using a  purified monoclonal mouse IgM  (ABPC-22)  in this latter 
assay.  Counts for both RF and IgM levels were referred to this same standard curve. Anti- 
thymocyte antibodies were  assayed  by a  two-step  chromium release  test  similar to  that  of 
Raveche et al. (27), using as targets C57BL/6 thymocytes. Complement levels were determined 
as described (28). Comparative hemolytic values were established using pooled BALB/c serum 
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TABLE  I 
Murine SLE Mortality 
50% Mortal-  90% Mortal-  Mice  Sex  Number 
ity  ity 
NZB  female  22  16"  21 
male  21  17  23 
NZB X W  female  19  8.5  12.8 
male  17  15  19 
MRL/I  female  17  5.0  7.3 
male  22  5.5  8.6 
MRL/n:[:  female  14  17  23 
male  14  23  27 
BXSB  female  17  15  24 
male  21  5.1  8.0 
* Age in months. 
:[: E. D. Murphy and J. B. Roths. Personal communication. 
IC in serum were detected and quantitated with a modification of the Raji cell radioimmune 
assay (RIA)  (29). We used aggregated mouse y-globulin (AMG) for the standard curve and 
12~I-IgG fraction of rabbit anti-mouse IgG for quantitation of Raji cell-bound IgG.  Pooled 
BALB/c serum stored at -70°C was the source of complement in the standard curve. Results 
are expressed  as micrograms equivalents of AMG/ml murine serum. 
Serum concentrations of gp70 were determined by a modification of a described RIA (30) 
that uses goat anti-feline leukemia virus as the primary antibody and 125I gp70 from Rauscher 
leukemia virus as the labeled antigen. The presence of antibody to AKR gp70 or to Rauscher 
gp70 was determined by using a radioimmune assay in which the primary binding was to 125I 
radiotabeled AKR gp70 or Rauscher gp70 followed  by precipitation with rabbit anti-mouse 
IgG. 
Co~oglobulin Isolation.  Cryoglobulin was separated from serum as described (31). Protein was 
determined  with  the  Folin method  and  IgG  concentration with  radial  immunodiffusion. 
Qualitative analysis of cryoglobulin was performed by double immunodiffusion  using antisera 
against murine Ig isotypes  and murine C3. ANA and antibody to DNA and AKR gp70 were 
determined as in serum. 
Elution of Igfrom Kidneys.  Kidneys from each of the strains (NZB ×  W, MRL/I and BXSB) 
were pooled, homogenized, and washed 5 times in phosphate buffered saline (PBS). After the 
final centrifugation, the precipitates were suspended in 5 ml PBS containing  0.005M Ca  ++ and 
0.01 M  Mg  ++, digested with DNAse (32), and eluted with KSCN in PBS (33). Titers of ANA 
and antibodies to ds DNA, ss DNA, and gp70 at multiple dilutions were  determined in the 
respective sera and kidney eluates. The ratio of IgG in the serum relative to the kidney eluate 
at the endpoint titer indicated the degree of antibody concentration in the tissue. 
Results 
Mortality.  Table I  lists the age in months of the four immunologically abnormal 
murine strains at  the time of 50% and 90%  mortalities. The lupus-like syndrome in 
female and male MRL/1 mice and male BXSB mice was considerably earlier in onset 
and more acute than that of the NZB  ×  W  female. 
Clinical Picture.  A marked, generalized lymphadenopathy was evident in virtually 
all male and female MRL/I older than 3 mo and in ~  10% of the older male BXSB 
mice.  NZ mice did not develop clinically evident lymphadenopathy. In about one- 
third of MRL/I mice, the lymph nodes shrunk markedly 7-I0 days before death. 
Heavy proteinuria and associated anasarca was  most  frequent in the NZB  ×  W 
females. At 4  mo of age these mice had a  mean urinary protein of 6.6 mg/day and 
terminally 40% had advanced anasarca. MRL/I males and females and BXSB males ANDREWS ET AL.  1201 
between 3 and 6 mo of age had urinary protein values from 2.6 to 3.8 mg/day with 
an incidence of terminal anasarca approximately one-half that found in the NZB  × 
Ws. 
Histologic Observations.  At autopsy there were many histopathologic similarities in 
the mice with relatively early SLE: BXSB male, MRL/I female, MRL/I male, and 
NZB  x  W  female.  The  major  cause  of death  in  all  four  of these  groups  was 
glomerulonephritis which ranged from an exudative and proliferative acute form in 
the  BXSB  male  to  a  largely subacute  proliferative form in  the  MRL/I  male  and 
female and a  more chronic obliterative form in the NZB  X  W  female (Fig.  1 A, B, 
and  C)  (Table II).  Only in  the BXSB  mice were polymorphonuclear leukocytes a 
significant element in the glomerular lesions. In the MRL/I mice glomerular lesions 
involved proliferation of both endothelial and mesangial cells with occasional crescent 
formation and basement  membrarre thickening. The obliterative lesion in the NZB 
x  W  female  was  accompanied  by  heavy  mesangial  and  at  times  intravascular 
proteinaceous deposits, proliferation of all glomerular cellular elements, and frequent 
crescent formation. 
15-30% of mice in each group had old and/or acute myocardial infarction involving 
either ventricle and judged extensive enough to be a contributing cause of death (Fig. 
1 E). Although coronary arterial disease usually was not evident, there were occasional 
instances of hyalin thickening of small arteries in or near the infarcts as well as of 
arteries unrelated to myocardial lesions. Acute polyarteritis most frequently involving 
renal  and  coa'onary arteries occurred in  over one-half of female and  male  MRL/I 
animals (Fig.  1 D) but in none of the BXSB or NZB  ×  W  mice. In spite of the high 
incidence of  coronary arteritis in MRL/I mice, their incidence of myocardial infarction 
was the same as that of the BXSB and NZB  X  W suggesting that arteritis, per se, did 
not predispose significantly to myocardial infarction. 
20-25% of old, sick MRL/I mice had swelling of the joints and surrounding tissues 
of the  hind  feet  and  lower  legs.  These  lesions  consisted  of an  acute  to  chronic 
inflammatory process in the absence of detectable cutaneous abnormality. There was 
destruction of articular cartilage, proliferation of synovium, pannus formation, and, 
at times, joint effusions which in toto produce a picture not unlike that of rheumatoid 
arthritis. The periarticular tissues were involved in acute and/or chronic inflammation 
with occasional foci of necrosis reminiscent of rheumatoid nodules. 
Thymic atrophy, most severe in the cortex but also involving the medulla in most 
mice,  was  similar  in  all  groups.  The  initial  lesion  appeared  to  be  loss  of cortical 
thymocytes with later degeneration, often cystic, of the medulla. In 5-10% of mice in 
each group, there appeared to be a  medullary or stromal hyperplasia which main- 
tained or even increased the normal size of the thymus in spite of a loss of cortex. This 
medullary  hyperplasia  did  not  correlate  consistently  with  any  other  clinical  or 
pathologic feature of the mice. 
The degree of lymph node hyperplasia varied considerably among the  different 
strains resulting in lymph nodes ranging from normal to two or three times normal 
size in NZB  X  W  females, to  10 to 20 times normal size in BXSB males, and up to 
100  times  normal  size in  MRL/I  mice. In  the  largest aaodes  of about  one-third of 
BXSB males, there was a  diffuse loss of lymphocytes with fibrosis of the remaining 
stroma. In one-third to one-half of MRL/I mice, the larger nodes showed extensive 
hemorrhage and cystic necrosis that was probably responsible for the clinically evident 
terminal reduction in lymph node size. 1202  MURINE  SYSTEMIC  LUPUS  ERYTHEMATOSUS ANDREWS  ET  AL. 
TABLE  II 
Murine SLE Histologic Observations 
1203 
Mice 
NZB  x  W 
(20)" 
MRL/I (18) 
MRL/I (23) 
BXSB  (20) 
Sex 
Female 
Female 
'Male 
Male 
Kidneys  Heart  Blood vessels  Lungs  Miscellaneous 
No vasculitis  Chronic  Gn~ 
(19) severe 
Acute  and sub- 
acute Gn (18) 
severe 
Subacute  Gn 
severe  (21) 
moderate  (2) 
Acute  and  su- 
bactueGnse- 
vere  (17) 
moderate  (3) 
Acute  (2)  and 
healed  (1)  in- 
farcts 
Acute  (3)  and 
healed  (3)  in- 
farcts 
Acute  polyar- 
teritis  (10) 
Thymus  Lymph nodes 
Severe  cortical  Normal  to  slight 
atrophy  (20)  hyperplasia 
medullary  hy-  (19) 
perplasia  (I) 
Severe  cortical  Extreme  hyper- 
atrophy  (18)  plasia  (17)  Be- 
medullary  by- I  crasis and hem- 
perplasia (2)  orrhage (7) 
Pneumonia  (2) 
lymphoid infil- 
trate (14) 
Pneumonia  (2) 
Acute  (2)  and 
healed  (1)  in- 
farcts 
Acute  (4)  and 
healed  (I)  in- 
farcts 
Acute  polyar- 
teritis  (13) 
No vasculitis 
Severe  cortical 
atrophy  (23) 
medullary  hy- 
perplasia (2) 
Severe  cortical 
atrophy  (20) 
medullary  hy- 
perplasia (l) 
Extreme  hyper-  Pneumonia  (8) 
plasia  (21)  ne-  lymphoidinfil- 
crosis and hem-  trate  (7)  carci- 
orrhage (8)  noma (1) 
Moderate  hyper-  Pneumonia  (6) 
plasia  (19)  Be-  adenoacan- 
crosis :t: fibrosis  thoma 
(6) 
! Lymphoma  ([ 
anasarea  (8: 
! Focal  hepatil 
necrosis  (2 
anasarca  (3 
arthritis (3) 
Thyroiditis  (Ii 
anasarca  (11 
arthritis (5) 
ICirrhosis  (1)  an 
asarca (4) 
* Number of animals. 
Gn - glomerulonephritis. 
In the 81  mice observed  throughout  life,  three  tumors developed:  a  lymphoma in 
NZB  ×  W  female, a carcinoma of the lung in an MRL/I male, and an adenocanthoma 
of the lung in a  BXSB  male. 
Immunofluorescence  Studies.  Granular  deposits  of  mouse  IgG  and  C3  of  variable 
intensity  were  present  in  one  or more  locales  including  glomerular  capillary  walls, 
mesangia, and tubulointerstitial  sites in the three strains of mice (Fig.  2). The patterns 
of glomerular IgG and C3 deposits in the three strains overlapped sufficiently  so that 
they  could  not  be  identified  with  certainty  in  most  individuals  from  each  strain; 
however, some general characteristics  were evident.  In the NZB  ×  W  mice, deposits 
were  present  largely  in  the  glomerular  mesangium  at  or before  5  mo of age.  With 
progression  of disease  and widening of the glomerular  mesangium,  heavy mesangial 
deposits  occurred,  generally  with  accompanying  glomerular  capillary  wall  deposits 
(Fig.  2 A).  A  predominant  or exclusive  glomerular capillary  wall pattern  of deposits 
was also occasionally seen. Extraglomerular renal deposits of IgG and C3 were present 
in the peritubular  tissue and arterioles  and increased  in frequency with age. 
Striking glomerular deposits of IgG and C3 involving both the mesangium and the 
glomerular  capillary  wall  of the  hypercellular  BXSB  glomerulus  were  observed  as 
Fro.  1.  A. Glomerulus of 9-mo-old female NZB X W. Typical of lesions in this strain are mesangial 
accumulation of amorphous material with proliferation of mesangial cells and hyaline thickening of 
peripheral capillary walls best seen in lower portion of glomerulus (periodic acid shift [PAS]-320 ×). 
B. Glomerulus of 5-too-old female MRL/I.  Primary lesion is a proliferation of mesangial cells and 
increased mesangial matrix. A few leukocytes are seen in capillary lumens hut peripheral capillary 
walls are not thickened. (PAS-320×).  C.  Glomerulus of 5-too-old male BXSB. Proliferation of 
mesangial and  endothelial cells plus accumulation of polymorphonuclear leukocytes produce a 
typical  proliferative-exudative glomerulonephritis typical of renal disease in  this strain. (PAS- 
320×).  D.  Coronary artery of 5-mo-old female MRL/I.  Entire circumference of this artery is 
involved in a acute, necrotizing, inflammatory response which has obliterated the normal structure 
of the still patent vessel. (PAS-125 ×). E. Right ventricular wall of heart of 5-mo-old male BXSB. 
Acute  myocardial infarction involves entire thickness of right ventricle with normal septal and 
papillary muscle seen above. This degree of myocardial infarction was present equally in the three 
types of lupus mice. (PAS-50 × ). 1204  MURINE  SYSTEMIC  LUPUS  ERYTHEMATOSUS ANDREWS ET AL. 
TABLE III 
Murine SLE Serum IgG Levels 
1205 
Mice  Sex  Age  No. Mice  IgG (mg/ml)* 
r¢/o 
NZB  Female  3  10  14.4 4- 3.6 
6  10  16.0 4- 3.6 
9  21  14.2 4- 7.0 
NZB ×  W  Female  3  15  8.8 4- 2.2 
6  15  15.0 4- 6.3 
9  31  11.0 4- 7.4 
MRL/I  Male &  2-3  16  15.6 4- 8.0 
female  4-5  26  26.0 4-  14.7 
BXSB  Male  3  22  7.4 4- 4.7 
5  21  19.2:1:12.0 
BALB/c  Male & female  4-6  10  3.5 :t: 0.9 
* Mean 4- SD. 
early as 3 mo (Fig. 2 B and C). Extraglomerular deposits similar to those in the NZB 
X  W  mice increased in frequency with age (Fig. 2 G). 
Granular IgG and C3 deposits in the MRL/I strain also increased from 2 to 5 mo 
(Fig. 2 E). The deposits were present in both the capillary wall and the mesangium, 
often tending to predominate in the former where the finely granular deposits were in 
general closely approximated. 
Murine retroviral gp70 was detectable with a  goat anti-Rauscher gp70 antisera in 
granular glomerular and tubular basement membrane deposits (Fig. 2 D, F, and H); 
however, the deposits were often much less striking and distributed differently than 
the  IgG  and  C3  deposits;  some  or  all  glomeruli  of  mice  with  impressive  IgG 
accumulations had no gp70. The variability of gp70 straining and its disparity with 
IgG and C3 were greatest in the MRL/1 strain. At best, equivocal staining with p30 
antiserum was seen in rate glomeruli of occasional mice in each strain. 
Serum  Protein Analysis.  The  allotype  of  the  IgG2A  subclass  (Ig-1  locus;  kindly 
determined by Dr. Leonard Herzenberg, Stanford, Calif.) for the MRL/1 and MRL/n 
strains is a, whereas that of the BXSB strain is b. The comparable marker for the NZB 
and NZW strains is  known to  be e  (34).  All autoimmune strains had  significantly 
higher  IgG  concentration that  the  BALB/c  controls  (Table III).  The  highest  IgG 
Fro. 2.  A. Granular deposits of IgG, accompanied by C3 and gp70, were observed within the 
mesangium and glomerular capillary walls of a 9-mo-old NZB  ×  W female. B. Heavy granular 
deposits of IgG, accompanied by C3 and small amounts of gp70, were present in the glomerular 
capillary walls and mesangium of a 6-mo-old BXSB male. C.  Diffuse granular deposits of IgG, 
accompanied by C3, were present in the glomerular capillary walls, and to a lesser extent in the 
mesangium, of a 5-too-old  BXSB male. Focal nuclear IgG deposits (arrow) were also found. D. gp70 
deposits in a glomerulus from the BXSB mouse shown in C are illustrated. E. Diffuse granular IgG 
deposits were found along the  glomerular basement membranes of a  5-mo-old MRL/I  male. 
Granular deposits of IgG (arrows) were also present in the tubular basement membranes. F. gpT0 
deposits were seen in a glomerulus from a 4-mo-old  MRL/I male, predominantly in the glomerular 
capillary wall and corresponding closely to the IgG and C3 deposition seen in this mouse. G. Foeal 
granular deposits  of IgG, accompanied by C3, were observed  within the tubular basement membrane 
and peritubular  capillary wall of a 8-mo-old BXSB male. t].  gp70 deposits (arrow) were also 
observed in the tubular basement membrane of the mouse depicted in G. (Original magnifications: 
A, ×  400; B,C,D,E,G,H, ×  312; and G, ×  500. Staining A,B,C,E,G, anti-mouse IgG; D,F,H, anti- 
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TABLe IV 
Murine SLE ANA 
Mice  Sex 
Age 
2-3 mo  5-6 mo  9 mo 
NZB  Female  0.4* (37):[:  0.5 (150)  6  (83) 
NZB ×  W  Female  0.2 (180)  13  (208)  43  (23) 
MRL/I  Male  14  (45)  192  (29)  § 
Female  89  (33)  182  (22)  § 
BXSB  Male  9  (33)  23  (22)  § 
BALB/c  Male &  0.2 (22)  0  (36)  0.2 (11) 
female 
* Values shown are geometric mean titers. 
~: Number of animals are included in the parentheses. 
§ No survivors. 
concentrations were seen in the MRL/1 mice which averaged nearly five times control 
at 2-3 mo and eight times at 4-5 mo. 
The  most striking  feature  of the  serum  protein  electrophoresis  was the  relatively 
high  incidence  of monoelonal  y-globulins in  the MRL/1  mice,  particularly  in their 
last  3  wk  of life.  Overall,  43%  of both  male  and  female  MRL/I  had  monoclonal 
protein  with two bands detected  in one animal.  Monoclonal proteins were found in 
23% of BXSB mice and  13% and  17% of NZB and NZB  ×  W  females,  respectively, 
although the latter's bands were much less prominent than those seen in the MRL/I. 
Diffuse hypergammaglobulinemia  was most marked  in MRL/Is followed by BXSB 
and then the NZB  ×  W. 
Direct  Anti-E~ythrocyte Antibody Test.  Erythrocyte  autoantibodies  occurred  most 
frequently in the NZB female with incidence of 5% at  3 mo, 32% at 6  mo, and 89% 
at 9 mo. NZB  ×  W  females, though having only 11% incidence at 6 mo, had 78% at 
9 mo. In the MRL/I  males and females, the incidence of anti-erythrocyte antibodies 
reached 4% and  1 I%, respectively, and  18% of the BXSB males were positive at  5-6 
mo. 
Anti-nuclear Antibodies.  ANA levels  (Table IV) were highest in MRL/1  mice, with 
the next highest titers  in NZB  ×  W  females, followed by BXSB males.  In all strains 
tested,  a  peripheral  or rim pattern  of nuclear fluorescence was always present  at the 
highest positive serum dilution, whereas the homogeneous pattern was sometimes seen 
at lower dilutions. 
Anti-dsDNA  and  Anti-ssDNA  Antibodies.  Anti-dsDNA  antibodies  developed  rela- 
tively  late  in  the  course  of murine  SLE  with  none of the  affected  strains  showing 
significant levels at 2 mo (Table V). At 4-5 mo all immunologically abnormal strains 
had significant  levels of anti-ds DNA. The highest  levels of anti-dsDNA were found 
in the 4- 5-mo-old MRL/1 and the 9-mo-old NZB  ×  W. 
Anti-ssDNA antibodies are found at low concentrations in immunologically normal 
mice  (Table  V).  However,  greater  increases  in  these  antibodies  were  found  in  the 
NZB,  NZB  ×  W, and  MRL/I  animals  at  2  mo and even higher levels observed at 
4-5 mo, at which time male BXSB also had abnormal levels. 
Sera  were also  tested  for anti-Sm  antibodies  and,  with  one exception  these  were 
found only in the MRL/I and MRL/n  animals of both sexes (26). 
Rheumatoid Factor.  As seen  in Fig.  3, significant elevations of RF were found only ANDREWS ET AL.  1207 
TABLE V 
Murine SLE Serum dsDNA and ssDNA Binding Activity* 
Mice  Sex 
Anti-dsDNA  Anti-ssDNA 
2 mo  4-5 mo  9 mo  2 mo  4-5 mo  9 mo 
NZB  Male & female  <5  6  10  29  41  54 
NZB X W  Female  <5  7  21  34  67  69 
MRL/I  Male & female  <5  25  :~  33  81  :~ 
BXSB  Male  <5  8  ~  10  25  :~ 
Female  <5  <5  <5  9  10  10 
BALB/c  Male & female  <5  <5  <5  8  10  9 
* Expressed as % binding  of 20 ng x=SI-ssDNA  or 1~I-dsDNA  by 100 #l 1:10 mouse serum. 
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FIG. 3.  Rheumatoid factor and serum IgM concentrations. O, NZB female; O, normal females 
CBA/St and C57BL/6 St; A, BXSB male; A, NZB ×  NZW female; ~7, MRL/I male and female. 
in about one-half of the MRL/1 mice and in a  single NZB  X  W.  Normal CBA/St 
and C57BL/6 St mice had RF concentrations comparable to or higher than the levels 
found in BXSB  males and NZB  ×  W  females. The concentrations of RF  in NZB 
mice were within the upper normal range. 
Anti-thymocyte antibodies.  Male and female NZB and female NZB  ×  W  mice have 
unusually high  incidences of positivity ranging from  60  to  78%.  Male  and  female 
BXSB  and NZB  X  W  male mice are from 20 to 40% positive and MRL/I  mice of 
both sexes  are  10%  positive, all of which  are  well within the  levels found in most 
immunologically normal mice. 
Serum Complement.  In all types of mice with a  lupus-like syndrome the concentra- 
tions of hemolytic complement fell with age  (Fig. 4).  The progressive fall in serum 
complement concentrations began with  the  onset  of disease and progressed  as  the 
immunologic abnormalities increased. 
Circulating IC.  The  upper  normal  limit  of IC  in  the  sera  of  10  /xg equivalent 
AMG/ml  was  based  on the  mean plus two  standard deviations for  a  group  of 37 
control BALB/c mice measured at 3, 6, and 9  mo (Fig. 5). Abnormal levels of IC in 1208  MURINE  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
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TABLE VI 
Serum Retroviral  gp 70 at 2-4 Mo 
Mice  Female  Male 
NZB  36* (13)$  64 (16) 
NZB ×  W  25  (61)  43 (48) 
MRL/I  20  (3)  24 (42) 
BXSB  8  (33)  17 (46) 
NZW  34  (24)  68 (28) 
LGJ  --  58 (13) 
129/J  --  21 (17) 
SWR/J  --  11 (5) 
C57B1/6  --  3 (15) 
BALB/c  --  2 (12) 
* #g gp70/ml. 
:~ Number animals tested. 
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NZB  ×  W  mice were first observed at 6 mo in =  80% of the mice with a  mean of 45 
#g.  NZB  X  W  mice with obvious disease at  the age of 9  mo had mean  IC levels of 
144/~g with ;~ 90% of the animals having values above normal. NZB females showed 
elevations  in  circulating  IC  at  3,  6,  and  9  mo  with  values  of 51,  87,  and  115  #g 
equivalent,  respectively.  BXSB males had barely elevated IC levels at 2 mo, but at 3 
mo the mean was 41/lg equivalent  with 50% of animals having abnormal levels.  At 
5 mo the mean was  178 with 84% of the animals showing elevation.  The highest  IC 
levels were detected  in MRL/1 males and females which at  2-3 mo had IC levels of 
90 and at 4-5 mo mean values of nearly 900. This measurement of IC was determined 
to be unrelated to the hyperimmunoglobulin levels in these mice. Further, removal of 
serum cryoglobulins did not significantly reduce the IC levels. 
C~yoglobulins.  Control  levels of cryoglobulins were determined  from observations 
on normal BALB/c mice in which the mean levels were  134 btg/ml at  3 mo and 206 
~g/ml  at  9  mo.  Comparatively,  NZB  ×  W  female  mice  had  slightly  elevated 
cryoglobulin levels of ~  200/~g/ml at 3 mo and slightly >300/~g/ml  at 6  and 9 mo. 
NZB female mice had larger amounts of cryoglobulin with concentrations  of ~  350 
/zg/ml at 3 and 6 mo, and 570 #g/ml at 9 mo. BXSB males had elevated cryoglobulins 
of 472 #g/ml at  2 mo followed by decreases to 260 #g/ml at  3 mo and 275 #g/ml at 
5  mo. The most striking concentrations of cryoglobulins were found in MRL/1 mice 
of both sexes in which values went from  173/~g/ml  at  2 mo to 2,180 ~tg/ml at 5 mo. 
IgM and  IgG1 were most frequently  found in cryoprecipitates  of all  mice tested; 
followed by IgG2A. C3 was found in  20%  of the cryoglobulins of NZ mice,  50%  in 
those of the MRL/I,  but  only  11%  in those of the BXSB mice.  No concentration of 
anti-AKR, gp70, anti-dsDNA, or anti-thymocyte antibodies were seen in the cryopre- 
cipitates over that seen in paired sera. 
Serum  Retroviral gp70.  Levels  of serum  retroviral  gp70  in  mice  with  lupus-like 
syndromes and normal mice are listed in Table VI. On the basis of structural studies, 
the serum gpT0 of normal and lupus mice is very similar to the gp70 of a Xenotropic 
retrovirus uniquely expressed in the NZB mouse (35, 36). Although NZ, MRL/1, and 
BXSB  mice  had  significant  levels  of serum  gp70,  similar  levels  were  observed  in 
several strains of immunologically normal mice. 
Antibody Activity in Renal Eluates.  The concentrations of ANA activity in IgG eluted 
from kidneys vs. the concentrations of ANA activity in serum  IgG was from 2 to  10 1210  MURINE  SYSTEMIC  LUPUS  ERYTHEMATOSUS 
times higher in individual eluates of NZB  ×  W  kidneys and 2 to 6 times higher in 
eluates from both MRL/1 and BXSB kidneys. Antibody against dsDNA was consid- 
erably more concentrated in NZB  ×  W  renal eluates being 25-31 times greater than 
in serum whereas MRL/1 eluates showed only a  1-6 times concentration and BXSB 
eluates 0-12 times. Antibodies to ssDNA were also more concentrated in renal eluate 
IgG than in serum IgG with values of 5-13 times for NZB  ×  W  and  11-21 times for 
BXSB  eluates.  Antibodies  to  Rauscher  gp70  and  to  AKR  gp70  were  not  found 
concentrated in renal lg eluates from any of the three SLE strains. 
Discussion 
All  SLE  mice  shared  a  number  of immunopathologic  features  that  appeared 
directly related to the progress of their disease. Common to all kinds of affected mice 
there were several primary serologic abnormalities including:  (a)  elevated serum Ig 
concentrations with associated monoclonal gammopathy, (b) ANA, and (c) antibodies 
to ssDNA and dsDNA. Of these serologic changes, the Ig concentrations which reflect 
the overall activity of the B cells appeared to correlate best, but by no means perfectly, 
with the severity of disease in the several strains. The MRL/I and BXSB mice had 
the most rapidly progressive disease and also had higher Ig concentrations and higher 
incidence of monoclonality than NZB  ×  W  and NZB mice. In addition, NZB, NZB 
×  W, MRL/I, and BXSB mice all show abnormally high spontaneous polyclonal B 
cell activation.  2 The ANA levels, which were elevated in all  mice, were highest  in 
MRL/I and only moderately elevated in BXSB in spite of equally rapid courses of 
disease in these two strains of mice. The ANA levels paralleled the course of disease 
within each strain reaching maximum levels at about the time of 50% mortality in 
each. Anti-ds and -ssDNA were in general elevated and paralleled each other within 
each strain but did not reflect the severity of disease in the several strains. BXSB and 
MRL/I mice had modest elevations whereas NZB  ×  W  mice had 2-3 times higher 
levels. 
Secondary serologic changes  related  completely or  in  part  to  antigen-antibody 
interactions were present in all three SLE strains. Levels of circulating IC paralleled 
the course of disease in each strain reaching maximum levels at about the time of 50% 
mortality.  However,  at  that  time  the  amounts  of IC  in  the  MRL/I  mice  were 
approximately four to six times higher than in the NZB ×  W and BXSB, respectively, 
in spite of equally acute disease courses in MRL/I and BXSB. Also the levels of IC 
varied considerably among the individual mice within each strain, and only in the 4- 
-5-mo-old MRL/I group did all individuals have significantly elevated values. Serum 
hemolytic complement levels reflected the immunologic events in the SLE mice with 
decreasing values as disease progressed. 
Histopathologic and immunopathologic study revealed several lesions common to 
SLE  in  all  strains  as  well  as  unique  lesions  especially  in  the  MRL/I.  The  most 
significant and constant component of the disease in all strains was a severe IC type 
glomerulonephritis. Consistent with the clinical course of SLE the glomerulonephritis 
was  acute  to subacute,  proliferative, and  exudative in  the  BXSB  male  and  more 
subacute,  proliferative in  the  MRL/I,  whereas  in  the  NZB  ×  W  the  disease was 
2 Izui,  S.,  McConahey,  P.  F.,  and  Dixon,  F.  J.  Increased  spontaneous  polyclonal  activation  of  B 
lymphocytes in mice with genetic autoimmune disease.J.  Iramunol. In press. ANDREWS ET AL.  1211 
subacute to chronic with heavier proteinaceous deposits both in the mesangia  and 
capillaries.  In  agreement  with  the  presence  of circulating  IC  and  presumed  IC 
pathogenesis  of  the  glomerulonephritis,  there  were  moderate  to  heavy  granular 
glomerular deposits of IgG and C3 in glomeruli of all SLE strains. These were most 
consistently found in greatest amount in the NZB  ×  W, perhaps because here the 
immunoproteins had the longest period in which to accumulate. The significance of 
the murine retroviral gp70 found in some glomeruli of all the SLE strains and most 
prominent  in  the  NZB  ×  W  was  uncertain.  Its  granular  glomerular distribution 
suggested  its  participation  as  the  antigen  in  some  of the  deposited  IC,  but  its 
distribution  often differed significantly from that  of the IgG and C3.  Quantitative 
interpretation  of immunofluorescence is  difficult,  however,  gp70  was  present  less 
regularly and  in  less  intensity than  IgG  and  C3  suggesting  that  if gp70  were  on 
antigenic component of the glomerular IC, it might be a minor one. This impression 
is borne out by the lack of concentration of anti-gp70 antibody in the Ig eluted from 
the SLE kidneys. 
A second consistent part of SLE pathology in all strains was severe thymic atrophy. 
This involved almost complete loss of cortex and in 90% of instances accompanying 
medullary atrophy. Whether this thymic atrophy was a primary or secondary event 
in the SLE was not possible to determine, but it was found before evident disease in 
kidneys or elsewhere. In addition, its development apparently did not correlate with 
incidence  of circulating  anti-thymocyte antibodies.  MRL/1  mice  had  a  very low 
incidence of these antibodies, and BXSB male mice had no more than many normal 
strains. Yet each had significant thymic atrophy by 4-5 too, as early or earlier than 
that  occurring  in  NZ  mice,  which  had  much  higher  incidences of antithymocyte 
antibodies. Further, the high incidence of anti-thymocyte antibodies in some immu- 
nologically  normal  murine  strains  suggests  that  these  antibodies  are  unrelated  to 
thymic atrophy,  a 
The  occurrence of myocardial  infarction  in  murine  SLE  has  not  been  noted 
previously, but  infarcts of significant size did occur in  15-30% of mice in all  SLE 
strains. Generally there was no obvious associated coronary vascular disease, except in 
the  MRL/I  mice,  about  one-half of which  had  an  acute  polyarteritis,  frequently 
involving the coronaries but unrelated to any increase in myocardial infarction. 
The degree and kind of hyperplasia of lymph nodes and spleens varied among the 
SLE strains much more than did the IgG levels or the levels of autoantihodies. Not 
only did lymphoid mass differ (1-3 times normal in NZB  ×  W  to 10-20 times normal 
in BXSB and  100 times normal in MRL/I) but the cell type involved also differed. 
The MRL/I  nodes were flooded with small  lymphocytes often obliterating normal 
nodal architecture. The major cell type in the hyperplastic nodes of the MRL/I was 
a  0 positive, Ly-null cell which was not seen in the other strains  (to be published). 
Late changes~ in  the nodes of the  BXSB  mice included progression of the stromal 
replacement, however, in the MRL/I there was often extensive cystic and hemorrhagic 
necrosis. Benign lymphoid infiltration of organs such as lung, kidney, and liver that 
increased with age was seen to some degree in all SLE strains but was most marked 
in the NZB  ×  W  perhaps because of their longer life. 
The differences in onset and severity of SLE in males and females of the several 
3 Elsenberg, R  A., Theofilopoulos,  A. N., Andrews, B. S, Peters, C. J, Thor, L, and Dixon, F J 
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strains, NZB  ×  W, females first; MRL/I, both sexes about equally, and BXSB, males 
first; suggest that there is no consistent or mandatory endocrine influence on murine 
SLE as it is seen in multiple strains. Although a  female endocrine enhancement and 
male  endocrine  suppresion  of SLE  in  NZB  ×  W  mice  has  been  reported  (37), 
preliminary results in BXSB mice indicate no sex hormone-related influence on the 
disease  in  this  strain  (to  be  published).  The  BXSB  male  parent  contributes  an 
accelerating factor to male offspring (19). 
Several  serologic abnormalities  including  IgM-RF,  anti-Sin  antibodies,  and  cry- 
oglobulins were found as part of the SLE-like syndrome in MRL/I mice, but not in 
BXSB  or NZB  ×  W.  Although  this might  in  part  relate to the extremely high  Ig 
levels in  this strain,  which might tend to magnify any borderline serologic changes, 
this is not the entire explanation.  MRL/n  mice which are closely related to MRL/1 
but without  lymphoproliferation or marked elevation of serum Ig also have anti-Sm 
antibodies  (25)  indicating  that  this immune response was an unique  product of the 
MRL  genome.  Also,  the  increased  IgM-RF in  the  MRL/I  occurred  without  much 
increase in the serum IgM level. IgG RF has also been found in the serum of MRL/I 
mice (to be published). It is tempting to relate these RFs to the arthritic lesions found 
in  the  hind  legs  and  feet  of MRL/I  mice.  Whether  these  two  manifestations  are 
pathogenetically  related  remains  to  be  determined,  but  with  both  serologic  and 
arthritic  changes  resembling  rheumatoid  arthritis  the  MRL/I  mouse  may  be  a 
valuable animal model for the study of this human disease. 
Definition of the role of retroviral gp70 in murine lupus is difficult because multiple 
immunologically related gp70 may be produced in every mouse. The primary serum 
gp70 of all mice so far tested is similar to that found in the NZB Xenotropic virus (36, 
37)  and because it is always in excess no serum antibody to it has yet been identifed. 
Mice also carry the genomes of one or more additional retroviruses the gp70s of which 
may  be  expressed  but  usually  in  far smaller  amounts  than  the  serum  gp70.  Free 
antibodies  to  some of these  non  serum gp70s  have been  detected  as  in  the  case of 
antibodies to Rauscher gp70 or to AKR gp70 in mice carrying the AKR viral genome. 
Although  gpT0 has been  identified  in  the glomeruli in murine lupus its type is not 
known. The considerable amounts of serum gp70 found in NZB and NZB  ×  W  have 
been suggested as an etiological factor in the diseases of these mice (5, 6).  However, 
in  view of:  (a)  the  lack of correlation  between  serum  gp70  levels  and  the  rate  of 
progression of disease in NZ and MRL/I and BXSB mice,  (b)  serum gp70 levels of 
many immunologically normal murine strains equal to those of mice with SLE, and 
(c) the lack of correlation of serum gp70 levels with autoimmune disease in crosses of 
NZB  and  SWR  mice  (38),  it  appears  that  high  serum  levels  of gp70  are  not  in 
themselves a  cause of murine SLE.  If retroviral gp70 proves to be significant  in  the 
pathogenesis  of murine  SLE it  is  more likely that  it  will  be an abnormal  immune 
response of the host to its gp70 which is the critical factor rather than any given level 
or unique type of gp70 in the circulation. 
Summary 
MRL/I  and  BXSB  male  mice  have  a  systemic  lupus  erythematosus  (SLE)-like 
disease  similar  to  but  more  acute  than  that  occurring  in  NZB  ×  W  mice.  The 
common  elements  of  lymphoid  hyperplasia,  B-cell  hyperactivity,  autoantibodies, 
circulating immune complex (IC), complement consumption, IC glomerulonephritis ANDREWS ET AL.  1213 
with gp70 deposition, and thymic atrophy were found in all three kinds of SLE mice. 
On the basis of these common elements, SLE seen in these mice can be considered a 
single disease in the same sense that human SLE is one disease. The differences in the 
SLE expressed in the different mice are no greater than those found in an unselected 
series  of humans  with  SLE.  However,  the  significant  quantitative  and  qualitative 
variations  in abnormal  immunologic expression suggest  that  different  constellations 
of factors, genetic and/or pathophysiologic, may operate in the three murine strains 
and that each constellation is capable of leading, via its particular abnormal immu- 
nologic consequences, to the activation of common immunopathologic effector mech- 
anisms that cause quite similar SLE-like syndromes. 
From  an  experimental  point  of view,  the  availability  of several  inbred  murine 
strains  of commonplace histocompatibility types that express an SLE-like syndrome 
makes possible innumerable manipulations which should help to elucidate the nature 
and cause(s)  of this disorder. 
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